These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2856925)

  • 1. Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
    Cohen JL; Vinik A; Faller J; Fox IH
    J Clin Invest; 1985 Jan; 75(1):251-7. PubMed ID: 2856925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover.
    Faller J; Fox IH
    N Engl J Med; 1982 Dec; 307(26):1598-602. PubMed ID: 7144847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of hyperuricemia in glycogen storage disease, type I.
    Roe TF; Kogut MD
    Pediatr Res; 1977 May; 11(5):664-9. PubMed ID: 266162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urate production in heterozygotes for glucose-6-phosphatase deficiency.
    Stormont D; Davies C; Emmerson BT
    Clin Chim Acta; 1976 Sep; 71(2):303-8. PubMed ID: 183920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders.
    Puig JG; Torres RJ; de Miguel E; Sánchez A; Bailén R; Banegas JR
    Metabolism; 2012 Apr; 61(4):512-8. PubMed ID: 22001332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia and hypertriglyceridemia: metabolic basis for the association.
    Fox IH; John D; DeBruyne S; Dwosh I; Marliss EB
    Metabolism; 1985 Aug; 34(8):741-6. PubMed ID: 4021806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucagon on the xylitol-induced increase in the plasma concentration and urinary excretion of purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Ohata H; Nakano T; Yamakita J; Higashino K
    Metabolism; 1996 Nov; 45(11):1354-9. PubMed ID: 8931639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amino acids on the plasma concentration and urinary excretion of uric acid and uridine.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ohata H; Yamakita J; Nakamo T; Higashino K
    Metabolism; 1999 Aug; 48(8):1023-7. PubMed ID: 10459568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol induced alterations of uric acid metabolism.
    Faller J; Fox IH
    Adv Exp Med Biol; 1984; 165 Pt A():457-62. PubMed ID: 6720411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate.
    Puig JG; Fox IH
    J Clin Invest; 1984 Sep; 74(3):936-41. PubMed ID: 6470146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet.
    Yamashita S; Matsuzawa Y; Tokunaga K; Fujioka S; Tarui S
    Int J Obes; 1986; 10(4):255-64. PubMed ID: 3771090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.